Myasthenia gravis patient and physician opinions about immunosuppressant reduction

Muscle & Nerve
Michael K HehirEmma Ciafaloni

Abstract

To reduce myasthenia gravis (MG) patient risk of immunosuppressant (IS) exposure adverse events (AEs), such as infections and malignancies, and to reduce treatment burden, international guidelines recommend decreasing IS dose in stable MG patients. Online surveys were conducted of self-identified MG patients and MG physician experts about the importance of IS dose reduction for MG patients who achieve prolonged periods of disease stability. Eighty-four percent of MG patients (n = 283) and 100% of physicians (n = 45) were concerned about long-term IS-associated AEs. Although both groups favored attempting IS reduction, they raised concerns including MG relapse, hospitalization, and uncertainty about the future. Presented with an estimated 12% significant relapse rate with IS dose reduction, 76% of patients would be willing to enroll in a randomized IS dose reduction trial. Patients and physicians favor considering IS dose reduction but are also concerned about potential negative sequelae.

References

Jul 21, 1998·Annals of the New York Academy of Sciences·A EvoliM Marciano
Aug 4, 2005·Journal of Neuro-oncology·Pasquale F Finelli
Aug 26, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C RozsaS Komoly
Dec 7, 2007·Muscle & Nerve·David GrobMurali Pagala
Feb 21, 2008·Nature Clinical Practice. Oncology·Huy TranMaher K Gandhi
Jul 15, 2009·Neurology·Anne Taraldsen HeldalFredrik Romi
May 25, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J B AndersenN E Gilhus
Nov 22, 2011·Muscle & Nerve·Jeffrey T GuptillDonald B Sanders
Feb 16, 2012·Muscle & Nerve·Jeffery T GuptillDonald B Sanders
Jul 3, 2013·Cold Spring Harbor Perspectives in Medicine·Jeremy R ChapmanGermaine Wong
Jul 10, 2013·Muscle & Nerve·Donald B SandersUNKNOWN Muscle Study Group
Oct 31, 2015·Brain and Behavior·Iain J McGurgan, Christopher McGuigan
Apr 21, 2016·The Medical Clinics of North America·Iliana DoychevaKymberly D Watt
Jul 1, 2016·Neurology·Donald B SandersPushpa Narayanaswami

❮ Previous
Next ❯

Citations

Oct 13, 2021·Neuromuscular Disorders : NMD·Nils Erik GilhusJacqueline Palace

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
J CooperJ Feldman
Current Neurology and Neuroscience Reports
Emma Ciafaloni, Donald B Sanders
The Journal of the American Osteopathic Association
Milind J Kothari
The Kaohsiung Journal of Medical Sciences
Sheng-Yao HsuMin-Yang Su
© 2021 Meta ULC. All rights reserved